We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
201
Spire Wealth Management
Virginia
– -$200K -917 Closed
AAM
202
Advisors Asset Management
Colorado
– -$178K -821 Closed
US Bancorp
203
US Bancorp
Minnesota
– -$169K -780 Closed
VFA
204
Valeo Financial Advisors
Indiana
– -$149K -687 Closed
GWM
205
Geneos Wealth Management
Colorado
– -$141K -646 Closed
EDRH
206
Edmond de Rothschild Holding
Switzerland
– -$130K -600 Closed
PNC Financial Services Group
207
PNC Financial Services Group
Pennsylvania
– -$115K -530 Closed
HI
208
Harbour Investments
Wisconsin
– -$104K -479 Closed
PAM
209
Panagora Asset Management
Massachusetts
– -$104K -479 Closed
BWA
210
BDO Wealth Advisors
Florida
– -$87K -402 Closed
Fifth Third Bancorp
211
Fifth Third Bancorp
Ohio
– -$82K -378 Closed
Deutsche Bank
212
Deutsche Bank
Germany
– -$80K -369 Closed
HNB
213
Huntington National Bank
Ohio
– -$67K -310 Closed
S
214
SignatureFD
Georgia
– -$67K -309 Closed
CA
215
Clearstead Advisors
Ohio
– -$66K -304 Closed
HCM
216
Horrell Capital Management
Arkansas
– -$65K -300 Closed
LWP
217
Lumature Wealth Partners
Georgia
– -$65K -300 Closed
PWA
218
Phoenix Wealth Advisors
North Carolina
– -$59K -270 Closed
IA
219
IFP Advisors
Florida
– -$53.3K -244 Closed
WIM
220
Westside Investment Management
California
– -$50 -235 Closed
SPIA
221
Steward Partners Investment Advisory
New York
– -$50.5K -233 Closed
AIC
222
Ameritas Investment Company
Nebraska
– -$49.7K -229 Closed
HI
223
Hudock Inc
Pennsylvania
– -$48K -224 Closed
Northwestern Mutual Wealth Management
224
Northwestern Mutual Wealth Management
Wisconsin
– -$42K -192 Closed
TFS
225
TrustCore Financial Services
Tennessee
– -$40K -183 Closed
7 8
9
10 11

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.